Journal of Surgery Concepts & Practice >

2020 , Vol. 25 >Issue 01: 1 - 5

DOI: https://doi.org/10.16139/j.1007-9610.2020.01.001

Experts forum

Research on standardized treatment of spontaneous rupture of hepatocellular carcinoma

Expand

Received date: 2019-12-18

  Online published: 2020-02-25

Fold

Cite this article

YE Feng, MA Di, CHEN Yongjun . Research on standardized treatment of spontaneous rupture of hepatocellular carcinoma[J]. Journal of Surgery Concepts & Practice, 2020 , 25(01) : 1 -5 . DOI: 10.16139/j.1007-9610.2020.01.001

References

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[2] 郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1):19-28.
[3] Sahu SK, Chawla YK, Dhiman RK, et al. Rupture of hepatocellular carcinoma: a review of literature[J]. J Clin Exp Hepatol, 2019, 9(2):245-256.
[4] Zhu Q, Qiao GL, Xu C, et al. Partial hepatectomy for spontaneous tumor rupture in patients with hepatocellular carcinoma: a retrospective cohort study[J]. Cancer Manag Res, 2017, 9:525-537.
[5] Schwarz L, Bubenheim M, Zemour J, et al. Bleeding recurrence and mortality following interventional management of spontaneous HCC rupture: results of a multicenter European study[J]. World J Surg, 2018, 42(1):225-232.
[6] Zhong F, Cheng XS, He K, et al. Treatment outcomes of spontaneous rupture of hepatocellular carcinoma with hemorrhagic shock: a multicenter study[J]. Springerplus, 2016, 5(1):1101.
[7] Sada H, Ohira M, Kobayashi T, et al. An analysis of surgical treatment for the spontaneous rupture of hepatocellular carcinoma[J]. Dig Surg, 2016, 33(1):43-50.
[8] Li J, Huang L, Liu CF, et al. Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: A case-control study[J]. World J Gastroenterol, 2014, 20(27):9121-9127.
[9] Sun P, Song Z, Hu Q, et al. Rupture of hepatocellular carcinoma following transarterial embolization/chemoembolization: two cases report and systematic review[J]. Chin Ger J Clin Oncol, 2013, 12(2):76-82.
[10] Zhu LX, Geng XP, Fan ST. Spontaneous rupture of hepatocellular carcinoma and vascular injury[J]. J Hepatobi-liary Surg, 2001, 136(6):682-687.
[11] Zhu LX, Liu Y, Fan ST. Ultrastructural study of the vascular endothelium of patients with spontaneous rupture of hepatocellular carcinoma[J]. Asian J Surg, 2002, 25(2):157-162.
[12] Lai EC, Lau WY. Spontaneous rupture of hepatocellular carcinoma: A systematic review[J]. Arch Surg, 2006, 141(2):191-198.
[13] Zhu LX, Wang GS, Fan ST. Spontaneous rupture of he-patocellular carcinoma[J]. Br J Surg, 1996, 83(5):602-607.
[14] Singh Bhinder N, Zangan SM. Hepatocellular carcinoma rupture following transarterial chemoembolization[J]. Semin Intervent Radiol, 2015, 32(1):49-53.
[15] Zou J, Li C, Chen Y, et al. Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma[J]. Oncol Lett, 2019, 18(6):6423-6430.
[16] Tu J, Jia Z, Ying X, et al. The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma[J]. Medicine (Baltimore), 2016, 95(49):e5606.
[17] Lee HS, Choi GH, Choi JS, et al. Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea[J]. Ann Surg Treat Res, 2019, 96(6):275-282.
[18] Rombolà F, Caravetta A, Mollo F, et al. Sorafenib, risk of bleeding and spontaneous rupture of hepatocellular carcinoma. A clinical case[J]. Acta Medica Cordoba, 2011, 54(4):177-179.
[19] Zhu Q, Li J, Yan JJ, et al. Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma[J]. World J Gastroenterol, 2012, 18(48):7302-7307.
[20] Yang T, Sun YF, Zhang J, et al. Partial hepatectomy for ruptured hepatocellular carcinoma[J]. Br J Surg, 2013, 100(8):1071-1079.
[21] Wu JJ, Zhu P, Zhang ZG, et al. Spontaneous rupture of hepatocellular carcinoma: Optimal timing of partial hepatectomy[J]. Eur J Surg Oncol, 2019, 45(10):1887-1894.
[22] Yoshida H, Mamada Y, Taniai N, et al. Spontaneous ruptured hepatocellular carcinoma[J]. Hepatol Res, 2015, 46(1):13-21.
[23] Matsumoto T, Chung H, Suginoshita Y, et al. Outcomes and prognostic factors in patients with spontaneously ruptured hepatocellular carcinoma[J]. Hepatogastroenterology, 2015, 62(140):942-946.
[24] Leung CS, Tang CN, Fung KH, et al. A retrospective review of transcatheter hepatic arterial embolisation for ruptured hepatocellular carcinoma[J]. J R Coll Surg Edinb, 2002, 47(5):685-688.
[25] Aoki T, Kokudo N, Matsuyama Y, et al. Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey[J]. Ann Surg, 2014, 259(3):532-542.
[26] Pinal-García DF, Nuño-Guzmán CM, Gómez-Abarca A. Spontaneous rupture of hepatocellular carcinoma in a young patient with fatal outcome[J]. Case Rep Gastroenterol, 2018, 12(1):19-26.
[27] 高志慧, 柏斗胜. 精准医学时代肝细胞癌破裂出血的诊治[J]. 外科理论与实践, 2018, 23(3):217-220.
[28] Zhu Q, Qiao G, Xu C, et al. Conditional survival in patients with spontaneous tumor rupture of hepatocellular carcinoma after partial hepatectomy: a propensity score matching analysis[J]. HPB(Oxford), 2019, 21(6):722-730.
[29] Mizuno S, Yamagiwa K, Ogawa T, et al. Are the results of surgical treatment of hepatocellular carcinoma poor if the tumor has spontaneously ruptured?[J]. Scand J Gastroenterol, 2004, 39(6):567-570.
[30] Portolani N, Baiocchi GL, Gheza F, et al. Parietal and peritoneal localizations of hepatocellular carcinoma: Is there a place for a curative surgery?[J]. World J Surg Oncol, 2014, 12:298.
[31] 刘炳琪. 原发性肝癌自发性破裂出血38例临床诊疗分析[D]. 山东大学, 2016.
[32] Wu CC, Ho YZ, Ho WL, et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal[J]. Br J Surg, 2010, 82(1):122-126.
[33] Sasaki A, Shibata K, Ohta M, et al. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma[J]. Eur J Surg Oncol, 2006, 32(7):773-779.
[34] Zheng SZ, Liu DJ, Sun P, et al. Feasibility and safety of sorafenib treatment in hepatocellular carcinoma patients with spontaneous rupture[J]. World J Gastroenterol, 2014, 20(43):16275-16281.
[35] Liao Y, Zheng Y, He W, et al. Sorafenib therapy follo-wing resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence[J]. Oncol Lett, 2017, 13(2):984-992.
Options
Outlines

/

〈 〉